Glaukos Corp. Hits Day High with Strong 7.43% Intraday Surge

Glaukos Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, gaining 7.43% on June 2, 2026. The stock reached an intraday high of USD 113.08, reflecting a notable performance compared to the S&P 500, which only increased by 0.13% on the same day. Despite this daily uptick, Glaukos Corp. has faced challenges over the past week, with a decline of 3.64%. The one-month performance indicates a more substantial drop of 21.0%, while the year-to-date figures show a slight decrease of 1.89%. However, the company has demonstrated resilience over the longer term, with a remarkable 348.68% increase over the past decade, outpacing the S&P 500's 261.47% growth. Financial metrics reveal a growth in operating profit of 17.44%, although the company reported a net profit of -37.8 million USD for the half-year. The operating cash flow stands at -20.62 million USD, and the return on capital employed (ROCE) is at -12.98%. With a market capitalization of USD 5,749 million, Glaukos Corp. continues to navigate a complex financial landscape.